Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system

被引:34
作者
Ng, P
Evelegh, C
Cummings, D
Graham, FL
机构
[1] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada
[2] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4K1, Canada
关键词
D O I
10.1128/JVI.76.9.4181-4189.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Helper-dependent (HD) adenovirus vectors devoid of all viral coding sequences have a large cloning capacity and provide long-term transgene expression in vivo with negligible toxicity, making them attractive vectors for gene therapy. Currently, the most efficient means of producing HD vectors involves coinfecting 293 cells expressing Cre with the HD vector and a helper virus bearing a packaging signal flanked by loxP sites. Cre-mediated packaging signal excision renders the helper virus genome unpackageable but still able to replicate and provide helper functions for HD vector propagation. Typically, helper virus contamination is less than or equal to1% pre- and less than or equal to0.1% postpurification by CsCl banding. While these contamination levels are low, further reduction is desirable. However, this objective has not been realized since the Cre/loxP system was first developed. This lack of progress is due, at least in part, to our lack of understanding of the origins of the contaminating helper virus, thus rendering its reduction or elimination difficult to achieve. This study was designed to investigate the possible sources of contaminating helper virus persisting during HD vector amplification. The results revealed that Cre is limiting in helper virus-infected Cre-expressing 293 cells, thereby permitting helper viruses to escape packaging signal excision and propagate. The results of this study should provide a foundation for developing rational strategies to further reduce or possibly eliminate the contaminating helper virus.
引用
收藏
页码:4181 / 4189
页数:9
相关论文
共 35 条
[1]  
ABREMSKI K, 1984, J BIOL CHEM, V259, P1509
[2]   Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors [J].
Addison, CL ;
Hitt, M ;
Kunsken, D ;
Graham, FL .
JOURNAL OF GENERAL VIROLOGY, 1997, 78 :1653-1661
[3]   SITE-SPECIFIC RECOMBINATION MEDIATED BY AN ADENOVIRUS VECTOR EXPRESSING THE CRE RECOMBINASE PROTEIN - A MOLECULAR SWITCH FOR CONTROL OF GENE-EXPRESSION [J].
ANTON, M ;
GRAHAM, FL .
JOURNAL OF VIROLOGY, 1995, 69 (08) :4600-4606
[4]   EFFECT OF ADENOVIRUS ON METABOLISM OF SPECIFIC HOST MESSENGER-RNAS - TRANSPORT CONTROL AND SPECIFIC TRANSLATIONAL DISCRIMINATION [J].
BABICH, A ;
FELDMAN, LT ;
NEVINS, JR ;
DARNELL, JE ;
WEINBERGER, C .
MOLECULAR AND CELLULAR BIOLOGY, 1983, 3 (07) :1212-1221
[5]   Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector [J].
Balagué, C ;
Zhou, JM ;
Dai, YF ;
Alemany, R ;
Josephs, SF ;
Andreason, G ;
Hariharan, M ;
Sethi, E ;
Prokopenko, E ;
Jan, HY ;
Lou, YC ;
Hubert-Leslie, D ;
Ruiz, L ;
Zhang, WW .
BLOOD, 2000, 95 (03) :820-828
[6]   INHIBITION OF HELA-CELL PROTEIN-SYNTHESIS DURING ADENOVIRUS INFECTION - RESTRICTION OF CELLULAR MESSENGER-RNA SEQUENCES TO THE NUCLEUS [J].
BELTZ, GA ;
FLINT, SJ .
JOURNAL OF MOLECULAR BIOLOGY, 1979, 131 (02) :353-373
[7]  
BERKNER KL, 1988, BIOTECHNIQUES, V6, P616
[8]   Persistence in muscle of an adenoviral vector that lacks all viral genes [J].
Chen, HH ;
Mack, LM ;
Kelly, R ;
Ontell, M ;
Kochanek, S ;
Clemens, PR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1645-1650
[9]   Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre [J].
Chen, LN ;
Anton, M ;
Graham, FL .
SOMATIC CELL AND MOLECULAR GENETICS, 1996, 22 (06) :477-488
[10]   Helper-dependent adenovirus vectors: their use as a gene delivery system to neurons [J].
Cregan, SP ;
MacLaurin, J ;
Gendron, TF ;
Callaghan, SM ;
Park, DS ;
Parks, RJ ;
Graham, FL ;
Morley, P ;
Slack, RS .
GENE THERAPY, 2000, 7 (14) :1200-1209